CRSP — Crispr Therapeutics AG Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual balance sheet for Crispr Therapeutics AG, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	944	1,690	2,379	1,815	1,694
Net Total Accounts Receivable
Net Total Receivables	0.099	0.144	0.305	0	200
Prepaid Expenses
Total Current Assets	988	1,717	2,418	1,853	1,908
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	72.8	93	312	321	306
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,067	1,828	2,752	2,243	2,230
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	57.1	94.3	120	121	109
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	127	164	352	368	347
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	939	1,664	2,399	1,875	1,883
Total Liabilities & Shareholders' Equity	1,067	1,828	2,752	2,243	2,230
Total Common Shares Outstanding